FRNT Financial Inc. Announces $3.0M Brokered Financing
April 05, 2024 19:43 ET | FRNT Financial
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 05, 2024 (GLOBE NEWSWIRE) -- FRNT Financial Inc. (TSXV:FRNT) (OTCQB:FRFLF)...
Leash Logo 1.png
Leash Biosciences Announces $9.3 Million Seed Financing to Pioneer AI-Driven Medicinal Chemistry
April 05, 2024 07:45 ET | Leash Biosciences
Leash Bio today announced the completion of a $9.3 million seed financing round and the launch of its inaugural machine learning Kaggle competition.
Carmell
Carmell Announces $3.0 Million Private Placement
April 04, 2024 08:30 ET | Carmell Corporation
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
DiagonalLogo_DarkColor.png
Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases
April 03, 2024 06:00 ET | DIAGONAL THERAPEUTICS, INC
Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies
02 - Aerial Shot 4
Sonnenblick-Eichner Company Arranges $19,500,000 of First Mortgage Financing for Texican Court, Irving, Texas
April 02, 2024 11:00 ET | Sonnenblick-Eichner Company
Sonnenblick-Eichner Company, on behalf of Valencia Hotel Group, arranges $19.5 million in first mortgage debt to refinance Texican Court in Irving, TX
abaxx logo.png
Abaxx Announces Closing of C$18,687,500 Bought Deal Financing Including Full Exercise of Over-Allotment Option
March 28, 2024 08:48 ET | Abaxx Technologies Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE CA:ABXX) (“Abaxx” or...
RAMM logo.jpg
RAMM Pharma Corp. Announces Corporate Update
March 19, 2024 09:29 ET | RAMM Pharma Corp.
TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
SENISCA full BLACK-solid (002).png
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease
March 18, 2024 03:00 ET | Senisca Ltd
SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease £3.7 million seed financing supported by consortium of new and...
UNCY Logo.jpg
Unicycive Announces $50 Million Private Placement
March 14, 2024 07:03 ET | Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for...